Kopta, Stephen M. – Trademark Portfolio
Entity Type: 01
Kopta, Stephen M. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BHM, CELESTHEALTH, and BEHAVIORAL HEALTH MEASURE--20. The owner is based in Newburgh, IN.
6033 Woodbidge Trail
Newburgh, IN 47630
Showing of trademarks Trademarks
Trademark Classifications
Kopta, Stephen M.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Kopta, Stephen M. have?
Kopta, Stephen M. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.
What trademark classes does Kopta, Stephen M. file in?
Kopta, Stephen M. files trademarks across 3 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are Kopta, Stephen M.'s most well-known trademarks?
Kopta, Stephen M.'s registered trademark portfolio includes well-known marks such as BHM, CELESTHEALTH, and BEHAVIORAL HEALTH MEASURE--20. These are among 3 currently registered trademarks in the portfolio.
What is Kopta, Stephen M.'s trademark registration success rate?
Kopta, Stephen M. has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.